ARCHIVES

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

This article is from The Cancer Letter archive.

Vol. 09 No. 25 | June 24, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992

Evaluation Finds OIG Provides PIs With Flexibility

June 14, 1991

DC, DCR Boards Angered when NCI Ignored In AIDS Money Amendment

October 26, 1984

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says.

September 24, 2004

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

October 28, 2005